Now on

Sirthalaclin clinical trial has started patient enrolment

The clinical trial Sirthalaclin for the treatment of transfusion-dependent beta-thalassemia patients has started patient enrolment.

News - read more
FDA grants ODD for the use of teicoplanin in Staphylococcus aureus infections in cystic fibrosis patients

FDA grants Orphan Drug Designation for the use of teicoplanin in Staphylococcus aureus infections in cf patients.

RP announcement - read more
Wellcome Trust supports the development of sirolimus in beta- thalassemia, a collaborative project between Rare Partners and Ferrara University

Wellcome Trust supports the development of sirolimus in beta - thalassemia, a collaborative project between Rare Partners and Ferrara University

News - read more
Orphan Drug Designation for the treatment of sickle cell disease also in USA

Sirolimus has been granted Orphan Drug Designation for the treatment of sickle cell disease also in USA

RP announcement - read more
Orphan Drug Designation to sirolimus in Sickle Cell Disease

Orphan Drug Designation to sirolimus in Sickle Cell Disease

RP announcement - read more